WebOct 21, 2024 · The label-free biomolecular characterization business (FortéBio) comprises innovative protein analysis instruments, biosensors and reagents that are … WebDec 19, 2011 · NEW YORK (GenomeWeb News) – Pall today said that it has signed an agreement to acquire protein analysis products firm ForteBio for an undisclosed sum. Menlo Park, Calif.-based ForteBio makes label-free protein analysis instruments that are expected to complement Pall's existing portfolio of microbiological monitoring platforms.
Pall to Acquire ForteBio - Yahoo Finance
WebPALL'S INDUSTRY EXPERTISE Biotech Food and Beverage Laboratory Medical Aerospace Chemicals & Polymers Industrial Manufacturing Microelectronics Oil & Gas … WebForteBio LLC is a wholly-owned subsidiary of Pall Corp. and a division of Pall Life Sciences. ForteBio develops analytical systems that enable real-time analysis of biomolecular interactions (protein quantification and characterization of protein-protein interactions, etc.) in micro-volume sample sizes, providing information on affinity, … ristorante thailandese imola
Pall to Acquire ForteBio - Yahoo News
WebDec 19, 2011 · NEW YORK (GenomeWeb News) – Pall today said that it has signed an agreement to acquire protein analysis products firm ForteBio for an undisclosed sum. … WebNov 15, 2024 · Direct measurement of biomolecular interactions plays an important role in biotherapeutic drug discovery and development. Label free analytical technologies such as the Octet® platform from Pall ForteBio provide a powerful means to obtain accurate information about rate of biomolecular complex formation and complex stability, key … WebBiomolecular interaction analysis, biosensor technology and surface chemistry, label-free, real-time assays, protein-protein interactions, small molecule and fragment screening, … smiles chem wikipedia